Cartilage Model for Drug Efficacy Evaluation
Solution Overview
Problem
Current animal models for evaluating arthritis treatments have limitations, including short administration periods and difficulty in accurately assessing drug efficacy, due to the need for invasive procedures and ethical concerns.
Innovation Solution
A method for producing a cartilage model through simultaneous culture of a porous natural polymer support and cartilage cells, allowing for the creation of cartilage models in growth, maturation, aging, and degeneration stages, which can be used to evaluate the effectiveness and safety of test substances.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal models are used to evaluate arthritis treatment substances, then drug effectiveness can be assessed, but the administration period is short and it is difficult to accurately evaluate drug efficacy
Solution Approach 1:
The patent creates a cartilage model that copies the structure and function of natural cartilage tissue, including the superficial layer, middle layer, deep layer, and calcified layer with tide marks. This artificial cartilage model replicates the key characteristics of real cartilage without requiring animal subjects, enabling long-term observation of drug effects on cartilage regeneration and protection.
Solution Approach 2:
The patent employs controlled parameter changes in the cartilage model by adjusting culture conditions (temperature, pH, nutrient supply) and treatment protocols to simulate different stages of cartilage development and degeneration. This allows the model to undergo controlled aging and healing processes over extended periods, providing accurate data on drug efficacy throughout the entire administration period.
2Reliability
If animal models are used for arthritis testing, then drug effectiveness can be evaluated, but it is impossible to quickly evaluate drug efficacy
Solution Approach 1:
The cartilage model serves as a simplified copy of the complex biological system, isolating the cartilage tissue from other organ systems. This allows focused observation of cartilage-specific responses to drugs without the variability introduced by animal physiology, accelerating the evaluation process while maintaining reliability.
Solution Approach 2:
The cartilage model is pre-prepared with controlled structure and composition before drug treatment begins. The model undergoes preliminary culture and conditioning to establish baseline characteristics, allowing immediate and rapid assessment of drug effects without the time required for animal model preparation and acclimation.
3Reliability
If animal models are used for testing, then drug effectiveness can be assessed, but invasive procedures and ethical concerns arise
Solution Approach 1:
The patent replaces animal models with an artificial cartilage model that copies the essential properties of natural cartilage. This substitution eliminates all invasive procedures and ethical concerns associated with animal testing while preserving the ability to evaluate drug effectiveness through controlled laboratory experiments.
Solution Approach 2:
The cartilage model acts as an intermediary system between the drug and the biological response. Instead of directly testing drugs on living animals, the model serves as a controlled intermediate that mediates the interaction, providing reliable data without the harmful effects of invasive animal procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cartilage models provide a reliable and long-term alternative for evaluating drug efficacy, enabling repeated or sequential treatment assessments and reducing the need for animal testing.
Implementation Method 1
simultaneously culturing a porous natural polymer support and a cartilage cell
Implementation Method 2
Cartilage cells act to produce and maintain articular cartilage
Data Source
AI summary
The present invention relates to a method for producing a cartilage model, comprising the step of simultaneously culturing a porous natural polymer support and a cartilage cell; a cartilage model produced by the method; and a method for testing the activity or toxicity of a test substance, comprising the step of treating the cartilage model with the test substance. A mature cartilage or aged cartilage model that can substitute an animal model may be produced using the method for producing the cartilage model according to the present invention, and the effectiveness and safety of the test substance may be accurately verified using the cartilage model thus produced, and thus, the cartilage model may be diversely utilized in the fields of new medicine development, disease research, and artificial organ development.



